Built on Established Science
Grounded in peer-reviewed research and translated into controlled bioprocess workflows.
Building a scalable marine biomanufacturing platform
Investor Area
Building a scalable marine biomanufacturing platform
We combine deep fish-cell biology, controlled bioprocessing, and partner-led scaling to deliver repeatable outputs across applications, focused on disciplined validation, de-risked scale-up, and partner-ready results.
Development Pipeline
Milestones toward industrial scale
BLUU’s development follows a stepwise, validation-driven path, from biological feasibility to partner-ready scale.
Biomanufacturing System
Proprietary marine cell lines established with validated cultivation and characterization workflows, forming a stable biological basis for downstream development.
Process Validation
Repeatable bioprocess parameters defined across lab and pilot environments, enabling controlled, consistent outcomes across runs.
Application Readiness
Personal care ingredients prioritized, with partner-facing evaluation materials and technical documentation in active development.
Scale-up Pathway
Pilot and pre-industrial scale pathways validated in collaboration with industrial partners, aligned with manufacturing constraints and partner requirements.
Quality & Documentation
Expansion of QA systems, traceability, and documentation frameworks to support regulated-market pathways and partner diligence.
Partner-led Scale
Industrial production roadmap executed through experienced manufacturing partners, enabling scale without CapEx-heavy infrastructure.
Proof
Evidence beyond the lab
BLUU’s platform has been validated through scientific results, external funding, industrial collaboration, and third-party recognition.
Why invest in BLUU
We build one platform and apply it precisely. The case for investment is based on what's already working, not on what's projected.
01 / Platform
A platform built for partners, not for pilots
BLUU operates within defined process windows from day one. Every output is documented, repeatable, and designed for partner evaluation — not internal demonstration.
02 / Applications
One process. Three markets.
The same marine cell biology applies across personal care, health, and food applications. We don't build separate solutions, we validate one process and deploy it where it fits.
03 / Compliance
Documentation built for regulated markets
Traceability, quality frameworks, and GMP-aligned processes are part of the core workflow — not an afterthought. Partners and regulators can evaluate with the material we already produce.
04 / Biology
Marine biology as a structural input
Fish cells produce compounds that land-based agriculture cannot replicate. BLUU's focus on marine-derived biology creates a category that isn't substitutable by existing ingredient supply chains.
LBBW Venture Capital
"BLUU is building the future of marine ingredients. Their biomanufacturing infrastructure has the potential to reshape the industry. We're proud to back this exceptional team."
— LBBW VC
Press Releases
Press
BLUU’s biotechnology
– A salmon leap of opportunities
The global leader in salmonid cell technology ventures beyond seafood into beauty and health.
• The world's leading provider of salmon cell technology is venturing beyond the seafood sec-
tor into the growth markets of beauty and health
• Ethically produced, traceable and highly effective ingredients can be extracted from the cul-
tured cells.
For press and partnerships, contact
contact@bluu.bio
Resources
Investor Deck (PDF)
Policies
Brand Assets (Logo, Imagery)
One-Pager / Executive Summary
Follow Our Process
Updates from BLUU on LinkedIn
We share selected milestones, scientific context, and company updates asthey happen.